Search results
The Next Wave of AI Gains is Starting
InvestorPlace· 9 hours agoAware that in-demand AI specialists can command several job offers, many companies are dangling salaries in the mid-six figures along with bonuses and...
US FDA approves expanded use of Bristol Myers' cancer cell therapy (May 15)
Reuters via Yahoo News· 5 days agoThe U.S. health regulator on Wednesday approved the expanded use of Bristol Myers Squibb's cancer ...
Arizona Grad Student Accused of Killing Professor in 2022 Had Planned the Crime, Prosecutor Says
US News & World Report· 8 hours agoA former University of Arizona graduate student accused of killing a professor on campus two years ago was in the midst of a psychotic episode at the time of the shooting, his attorney said ...
Study Offers New Detail on How COVID-19 Affects the Lungs
Columbia University News· 1 day agoNew research shows that ferroptosis, a form of cell death, occurs in severe COVID-19 patient lungs....
HaemaLogiX welcomes former Australian Federal Minister for Health Professor the Hon Greg Hunt to the...
WPRI Providence· 21 hours agoHaemaLogiX Ltd, a clinical stage biotech developing novel immunotherapies for patients with blood cancers and B-cell diseases, is pleased to announce the appointment of Professor ...
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
InvestorPlace· 14 hours agoIn addition, while the market has been robust – with the Dow Jones Industrial Average breaching the...
Minnesota lawmakers OK school policy changes on cell phones, book bans, literacy
MPR News· 5 days agoMinnesota lawmakers on Wednesday backed an education policy bill that prohibits book bans, requires...
Opinion | Why Biden won’t beat China by out-Trumping Trump on trade tariffs
South China Morning Post· 19 hours agoLast week, Biden announced a 100 per cent tariff on electric vehicles (EVs) from China, roughly a...
By listening, scientists learn how a protein folds
Phys.org· 12 hours agoMisfolded proteins contribute to Alzheimer's disease, Parkinson's disease, cystic fibrosis and other disorders. To better understand how this process...
Forbion-backed biotech Progentos debuts with $65M for MS drug
BioPharma Dive via Yahoo Finance· 17 hours agoProgentos says the money will go toward expanding its pipeline and pushing an experimental treatment...